SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-355664
Filing Date
2021-12-14
Accepted
2021-12-13 18:24:30
Documents
3
Period of Report
2021-12-13

Document Format Files

Seq Description Document Type Size
1 6-K d192493d6k.htm 6-K 11055
2 EX-99.1 d192493dex991.htm EX-99.1 34448
3 GRAPHIC g192493g1214040105122.jpg GRAPHIC 2050
  Complete submission text file 0001193125-21-355664.txt   49727
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 211489224
SIC: 2836 Biological Products, (No Diagnostic Substances)